文献速递脑血管病

脑微出血、抗凝与出血风险:房颤卒中患者荟萃分析

Brain microbleeds, anticoagulation, and hemorrhage risk: Meta-analysis in stroke patients with AF.
PubMed 文献 · Neurology · 2017-11-08

该荟萃分析纳入8个中心1552例近期缺血性卒中合并房颤且长期口服抗凝的患者,评估脑微出血(CMB)与未来自发性脑出血(ICH)风险的关联。结果显示CMB存在(OR 2.68)及≥5个CMB(OR 5.50)与ICH风险升高相关,年化ICH发生率从CMB阴性0.30%升至阳性0.81%及≥5个CMB 2.48%,但CMB与复发性缺血性卒中无关。

要点

  • 房颤卒中抗凝患者中,CMB存在者ICH风险约为无CMB者的2.68倍。
  • ≥5个CMB者ICH风险进一步升高(OR 5.50),年化发生率2.48%。
  • CMB与复发性缺血性卒中无显著关联,不影响抗凝缺血获益判断。

核心结论

  • MRI上CMB存在及≥5个CMB的二分截点可能识别房颤缺血性卒中后高ICH风险亚组。
  • 该指标经进一步验证后可能有助于风险分层、抗凝决策及指导随机试验和大型观察性研究。

研究设计与样本

  • 队列研究的荟萃分析,纳入近期缺血性卒中且记录房颤、基线脑MRI、长期口服抗凝、随访≥6个月且样本量>50例的研究。
  • 共纳入8个中心1552例患者,作者提供按CMB状态分层的卒中结局汇总数据。
  • 采用Poisson回归估计汇总年化ICH和缺血性卒中发生率,采用随机效应模型计算OR。

主要发现

  • CMB粗患病率为30%,≥5个CMB者为7%。
  • 基线CMB存在(对比无CMB)与随访期间ICH相关(OR 2.68,95%CI 1.19-6.01,p=0.017)。
  • ≥5个CMB与更高的未来ICH风险相关(OR 5.50,95%CI 2.07-14.66,p=0.001)。
  • 汇总年化ICH发生率从CMB阴性患者的0.30%(95%CI 0.04-0.55)升至CMB阳性患者的0.81%(95%CI 0.17-1.45,p=0.01),≥5个CMB患者为2.48%(95%CI 1.2-6.2,p=0.001)。
  • CMB与复发性缺血性卒中之间无关联。

临床怎么用

  • 对房颤缺血性卒中患者进行脑MRI评估CMB,尤其关注CMB数量是否≥5个,以辅助ICH风险分层。
  • CMB存在或≥5个时需在抗凝决策中权衡ICH风险,但证据尚需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To assess the association between cerebral microbleeds (CMBs) and future spontaneous intracerebral hemorrhage (ICH) risk in ischemic stroke patients with nonvalvular atrial fibrillation (AF) taking oral anticoagulants. METHODS: This was a meta-analysis of cohort studies with >50 patients with recent ischemic stroke and documented AF, brain MRI at baseline, long-term oral anticoagulation treatment, and ≥6 months of follow-up. Authors provided summary-level data on stroke outcomes stratified by CMB status. We estimated pooled annualized ICH and ischemic stroke rates from Poisson regression. We calculated odds ratios (ORs) of ICH by CMB presence/absence, ≥5 CMBs, and CMB topography (strictly lobar, mixed, and strictly deep) using random-effects models. RESULTS: We established an international collaboration and pooled data from 8 centers including 1,552 patients. The crude CMB prevalence was 30% and 7% for ≥5 CMBs. Baseline CMB presence (vs no CMB) was associated with ICH during follow-up (OR 2.68, 95% confidence interval [CI] 1.19-6.01, p = 0.017). Presence of ≥5 CMB was related to higher future ICH risk (OR 5.50, 95% CI 2.07-14.66, p = 0.001). The pooled annual ICH incidence increased from 0.30% (95% CI 0.04-0.55) among CMB-negative patients to 0.81% (95% CI 0.17-1.45) in CMB-positive patients (p = 0.01) and 2.48% (95% CI 1.2-6.2) in patients with ≥5 CMBs (p = 0.001). There was no association between CMBs and recurrent ischemic stroke. CONCLUSIONS: The presence of CMB on MRI and the dichotomized cutoff of ≥5 CMBs might identify subgroups of ischemic stroke patients with AF with high ICH risk and after further validation could help in risk stratification, in anticoagulation decisions, and in guiding randomized trials and ongoing large observational studies.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Charidimou A, Karayiannis C, Song TJ, et al. Brain microbleeds, anticoagulation, and hemorrhage risk: Meta-analysis in stroke patients with AF. Neurology. 2017. PMID: 29117953. doi:10.1212/WNL.0000000000004704

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。